Padcev Eiropas Savienība - čehu - EMA (European Medicines Agency)

padcev

astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastická činidla - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.

Equipramox 19,5 + 121,7 mg/g Čehija - čehu - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

equipramox 19,5 + 121,7 mg/g

continental farmaceutica - moxidektin, kombinace - perorální gel - milbemycins - koně